Michael Andrés Abril Gómez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Andrés Abril Gómez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ana Julia Reis
Universidade Federal do Rio Grande (FURG), R. Gen. Canabarro, 224 - Centro, Rio Grande - RS, 96200-200 - Brazil
1 shared publication - Ivy Bastos Ramis
Universidade Federal do Rio Grande
1 shared publication - Júlia Silveira Vianna
Universidade Federal do Rio Grande, Brasil
1 shared publication - Mariana Quaresma de Souza
Universidade Federal do Rio Grande, Brasil
1 shared publication - Pedro Eduardo Almeida da Silva
Universidade Federal do Rio Grande, Brasil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59, e0354
Challenges in the Diagnosis and Treatment of Mycobacterium abscessus Infections
The Mycobacterium abscessus complex (MABC) includes non-tuberculous mycobacteria that are widely distributed and clinically significant. Similar to tuberculosis, MABC can lead to skin and soft tissue infections and pulmonary diseases. These infections frequently occur in outbreaks, particularly among immunocompromised patients or those with preexisting pulmonary conditions. This review examines the recent progress in essential areas that define these infections as a significant challenge in medical practice, specifically the diagnostic modalities, antibiotic treatment options, and resistance of MABC to antibiotics and biocides.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59, e0354
Open AccessChallenges in the Diagnosis and Treatment of Mycobacterium abscessus Infections
The Mycobacterium abscessus complex (MABC) includes non-tuberculous mycobacteria that are widely distributed and clinically significant. Similar to tuberculosis, MABC can lead to skin and soft tissue infections and pulmonary diseases. These infections frequently occur in outbreaks, particularly among immunocompromised patients or those with preexisting pulmonary conditions. This review examines the recent progress in essential areas that define these infections as a significant challenge in medical practice, specifically the diagnostic modalities, antibiotic treatment options, and resistance of MABC to antibiotics and biocides.